Antioxidants for Alzheimer Disease | Zendy

Douglas Galasko | Zendy; Elaine R. Peskind | Zendy; Christopher M. Clark | Zendy; Joseph F. Quinn | Zendy; John M. Ringman | Zendy; Gregory A. Jicha | Zendy; Carl W. Cotman | Zendy; Barbara A. Cottrell | Zendy; Thomas J. Montine | Zendy; Ronald G. Thomas | Zendy; Paul Aisen | Zendy; for the Alzheimer's Disease Cooperative Study | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Antioxidants for Alzheimer Disease

Author(s) -

Douglas Galasko,

Elaine R. Peskind,

Christopher M. Clark,

Joseph F. Quinn,

John M. Ringman,

Gregory A. Jicha,

Carl W. Cotman,

Barbara A. Cottrell,

Thomas J. Montine,

Ronald G. Thomas,

Paul Aisen,

for the Alzheimer's Disease Cooperative Study

Publication year - 2012

Publication title -

archives of neurology

Language(s) - English

Resource type - Journals

eISSN - 1538-3687

pISSN - 0003-9942

DOI - 10.1001/archneurol.2012.85

Subject(s) - oxidative stress , vitamin e , placebo , medicine , mini–mental state examination , alzheimer's disease , biomarker , cerebrospinal fluid , cognitive decline , vitamin c , disease , gastroenterology , vitamin , physiology , antioxidant , pathology , dementia , biochemistry , chemistry , alternative medicine

To evaluate whether antioxidant supplements presumed to target specific cellular compartments affected cerebrospinal fluid (CSF) biomarkers.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research